Peofessor of Medical Biochemistry at University of Kufa, Iraq๐
ย Professor Dr. Hussein Kadhem Al-Hakeim is a distinguished Iraqi academic specializing in Medical Biochemistry, Biological Psychiatry, Insulin Resistance, and Nanobiochemistry. Residing at 28 Al-Adala, Najaf, Iraq, he is currently affiliated with Kufa University. Dr. Al-Hakeim is well-recognized for his significant contributions to biochemistry and clinical chemistry in Iraq.
Professional Profileย
Education๐
Dr. Al-Hakeim earned his B.Sc. in Chemistry from the University of Mosul in 1991, followed by an M.Sc. in Medical Chemistry and a High Graduate Diploma in Clinical Biochemistry from Al-Nahrain University in 2000 and 2001, respectively. He completed his Ph.D. in Medical Chemistry at the same institution in 2004. Additionally, he holds a Diploma in International Law and Diplomatic Relations from Cairo Regional Center for Training and Arbitration, obtained in 2017.
ย ๐ผWork Experience
Dr. Al-Hakeim has held various leadership roles, including Head of the Department of Chemistry at Kufa University and the University of Karbala. He has served as the Assistant Dean and Chief of the Examination Committee at the College of Science, University of Karbala. His teaching career includes extensive experience as a lecturer in postgraduate studies across multiple universities in Iraq.
ย ๐ ๏ธSkills
Dr. Al-Hakeim is an expert in Medical and Clinical Biochemistry, Nanobiochemistry, Insulin Resistance, and Stem Cell Technology. He has a profound knowledge of biostatistics, biosensors, and protein-nanoparticle interactions, and is skilled in advanced laboratory techniques and various biochemical analysis methods.
ย ๐Awards and Honors
Dr. Al-Hakeim’s work has been recognized at numerous scientific congresses and conferences worldwide. His research contributions and academic leadership have earned him a prominent place in Iraq’s scientific community.
ย Membership ๐๏ธand Affiliations ๐ค
๐Publications :ย
- IL-6, IL-18, sIL-2R, and TNFฮฑ proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation
- ๐๏ธ Year: 2015
- ๐ Journal: Journal of Affective Disorders
- Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses, and inflammation: a proof of concept
- ๐๏ธ Year: 2023
- ๐ Journal: Molecular Psychiatry
- Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients
- ๐๏ธ Year: 2011
- ๐ Journal: Asian Journal of Transfusion Science
- Intersections between pneumonia, lowered oxygen saturation percentage, and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID
- ๐๏ธ Year: 2021
- ๐ Journal: Journal of Affective Disorders
- The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments
- ๐๏ธ Year: 2022
- ๐ Journal: Molecular Psychiatry
- The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis
- ๐๏ธ Year: 2022
- ๐ Journal: medRxiv
- Serum levels of lipids, calcium, and magnesium in women with hypothyroidism and cardiovascular diseases
- ๐๏ธ Year: 2009
- ๐ Journal: Journal of Laboratory Physicians
- High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, andโฆ
- ๐๏ธ Year: 2020
- ๐ Journal: Schizophrenia Bulletin
- IL-10 is associated with increased mu-opioid receptor levels in major depressive disorder
- ๐๏ธ Year: 2019
- ๐ Journal: European Psychiatry
- Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precisionโฆ
- ๐๏ธ Year: 2023
- ๐ Journal: Acta Neuropsychiatrica
- The physio-affective phenome of major depression is strongly associated with biomarkers of astroglial and neuronal projection toxicity which in turn are associated withโฆ
- ๐๏ธ Year: 2023
- ๐ Journal: Journal of Affective Disorders
- Serum interleukin levels and insulin resistance in major depressive disorder
- ๐๏ธ Year: 2018
- ๐ Journal: CNS & Neurological Disorders – Drug Targets
- Lowered quality of life in long COVID is predicted by affective symptoms, chronic fatigue syndrome, inflammation, and neuroimmunotoxic pathways
- ๐๏ธ Year: 2022
- ๐ Journal: International Journal of Environmental Research and Public Health
- Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severityโฆ
- ๐๏ธ Year: 2020
- ๐ Journal: CNS Spectrums
- The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
- ๐๏ธ Year: 2022
- ๐ Journal: Brain, Behavior, & Immunity – Health
- The neuroimmune and neurotoxic fingerprint of major neurocognitive psychosis or deficit schizophrenia: a supervised machine learning study
- ๐๏ธ Year: 2020
- ๐ Journal: Neurotoxicity Research
- Serum apelin and galectin-3 in preeclampsia in Iraq
- ๐๏ธ Year: 2020
- ๐ Journal: Hypertension in Pregnancy
- Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia
- ๐๏ธ Year: 2020
- ๐ Journal: Current Topics in Medicinal Chemistry
- Estimation of Serum Copper, Manganese, Selenium, and Zinc in Hypothyroidism Patients
- ๐๏ธ Year: 2009
- ๐ Journal: IUFS Journal of Biology
- Major depression in children with transfusion-dependent thalassemia is strongly associated with the combined effects of blood transfusion rate, iron overload, and increased proโฆ
- ๐๏ธ Year: 2020
- ๐ Journal: Neurotoxicity Research